David Gaiero joined Light Horse Therapeutics as CFO in May 2025 on a part time basis. He is a partner with Monomoy Advisors, where he leads the Outsourced Finance team. Dave has held leadership roles in finance in start-ups and global publicly traded organizations. Prior to joining Monomoy, he most recently served as Chief Financial Officer of Cyteir Therapeutics. As Cyteir’s first internal finance hire, Dave rapidly built a fully functioning public company finance team with highly qualified staff and effective systems and processes, and he helped execute a $150 million IPO following an $80 million private crossover round. Before Cytier, Dave held various roles at Wave Life Sciences, most recently serving as Interim Chief Financial Officer and prior to that, serving as Vice President and Corporate Controller. Prior to joining Wave, Dave was Vice President and Corporate Controller of OvaScience, Inc. Prior to that, Dave held various positions of increasing responsibility and scope in finance and accounting at iRobot Corporation. Dave began his career in public accounting at PricewaterhouseCoopers LLP. He received his Bachelor of Business Administration in Accounting from the University of Massachusetts, Amherst, and is a Certified Public Accountant in Massachusetts. Dave has significant experience with financial operations, strategic planning and execution, SEC reporting, Sarbanes-Oxley implementation, systems implementation and all aspects of running a finance organization.